Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
For weight management purposes, B12 injections are not clinically indicated unless deficiency is documented
doi: 10.1007/s00592-015-0737-9 Summary Keywords metabolomics, ovarian cancer (OC), ovary, plasma, urine, hair Citation Zhong X, Ran R, Gao S, Shi M, Shi X, Long F, Zhou Y, Yang Y, Tang X, Lin A, He W, Yu T and Han T-L (2022) Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer
No oral, transdermal, or intranasal formulation of either compound has demonstrated clinically meaningful systemic bioavailability in humans
REQUEST A CONSULTATION Need help with an existing injury or ailment?
Athiras lead clinical candidate, fosgonimeton (formerly ATH-1017 / NDX-1017), is a structurally distinct phosphate prodrug of Dihexa not Dihexa itself
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
